Ferrovial, S.A. (FER):企業の財務・戦略的SWOT分析

◆英語タイトル:Ferrovial, S.A. (FER) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7658
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ferrovial, S.A. (FER) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ferrovial, S.A. (Ferrovial) is a heavy infrastructure and building construction contractor. It designs, constructs and maintains a wide range of projects, including roads, tunnels, highways, water treatment plants, maritime, hydroelectric plants, and railways. The company offers civil engineering; building refurbishment; and residential, nonresidential and industrial construction services for public and private sector clients. Ferrovial also carries out other businesses such as urban and environmental services; infrastructure and facilities maintenance; airports investment and operation; and toll road operations. It has operations in various countries such as the UK, the US, Australia, Spain, Qatar, Canada, Portugal, Spain, Ireland, Colombia, Greece, Australia, New Zealand, Chile and Poland. Ferrovial is headquartered in Madrid, Spain.

Ferrovial, S.A. Key Recent Developments

Jul 27,2018: Ferrovial to build and operate power transmission line in Chile
Jun 15,2018: Cintra’s Transform 66 project distinguished with three new awards
May 30,2018: Fidel Lopez Soria Appointed CEO Of Ferrovial Services
Mar 15,2018: Ferrovial Delivers New Water System to El Salado, Colombia
Feb 28,2018: Ferrovial reports 454 million euro net profit in 2017, a 21% increase

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Ferrovial, S.A. – Key Facts 6
Ferrovial, S.A. – Key Employees 7
Ferrovial, S.A. – Key Employee Biographies 8
Ferrovial, S.A. – Major Products and Services 9
Ferrovial, S.A. – History 10
Ferrovial, S.A. – Company Statement 21
Ferrovial, S.A. – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Section 2 – Company Analysis 25
Company Overview 25
Ferrovial, S.A. – Business Description 26
Business Segment: Airports 26
Overview 26
Performance 26
Key Strategies 26
Key Stats 26
Business Segment: Construction 26
Overview 26
Performance 26
Key Stats 27
Business Segment: Others 27
Overview 27
Performance 27
Business Segment: Services 27
Overview 27
Performance 27
Key Strategies 27
Key Stats 28
Business Segment: Toll Roads 28
Overview 28
Performance 28
Key Strategies 28
Key Stats 28
Geographical Segment: Australia 28
Performance 28
Geographical Segment: Canada 28
Performance 28
Geographical Segment: Others 28
Performance 28
Geographical Segment: Poland 29
Performance 29
Geographical Segment: Spain 29
Performance 29
Geographical Segment: UK 29
Performance 29
Geographical Segment: US 29
Performance 29
R&D Overview 29
Ferrovial, S.A. – Corporate Strategy 30
Ferrovial, S.A. – SWOT Analysis 31
SWOT Analysis – Overview 31
Ferrovial, S.A. – Strengths 31
Ferrovial, S.A. – Weaknesses 32
Ferrovial, S.A. – Opportunities 33
Ferrovial, S.A. – Threats 34
Ferrovial, S.A. – Key Competitors 35
Section 3 – Company Financial Ratios 36
Financial Ratios – Capital Market Ratios 36
Financial Ratios – Annual Ratios 37
Performance Chart 40
Financial Performance 40
Financial Ratios – Interim Ratios 41
Financial Ratios – Ratio Charts 42
Ferrovial, S.A., Recent Deals Summary 43
Section 4 – Company’s Recent Developments 44
Jun 15, 2018: Cintra’s Transform 66 project distinguished with three new awards 44
May 30, 2018: Fidel Lopez Soria Appointed CEO Of Ferrovial Services 45
Mar 15, 2018: Ferrovial Delivers New Water System to El Salado, Colombia 46
Feb 28, 2018: Ferrovial reports 454 million euro net profit in 2017, a 21% increase 47
Oct 26, 2017: Ferrovial reports 387 million euro net profit, a 39% increase, in first nine months of 2017 49
Jul 27, 2017: Ferrovial reports 27% growth in net profit to 240 million euro in the first half of 2017 51
May 04, 2017: Ferrovial reports 72 million euro net profit in the first quarter of 2017 53
Apr 03, 2017: Ferrovial Services brings the latest advances in energy efficiency to the University of Alcala 55
Feb 27, 2017: Ferrovial annual net income decreases 56
Section 5 – Appendix 57
Methodology 57
Ratio Definitions 57
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Ferrovial, S.A., Key Facts 6
Ferrovial, S.A., Key Employees 7
Ferrovial, S.A., Key Employee Biographies 8
Ferrovial, S.A., Major Products and Services 9
Ferrovial, S.A., History 10
Ferrovial, S.A., Subsidiaries 23
Ferrovial, S.A., Key Competitors 35
Ferrovial, S.A., Ratios based on current share price 36
Ferrovial, S.A., Annual Ratios 37
Ferrovial, S.A., Annual Ratios (Cont...1) 38
Ferrovial, S.A., Annual Ratios (Cont...2) 39
Ferrovial, S.A., Interim Ratios 41
Ferrovial, S.A., Recent Deals Summary 43
Currency Codes 57
Capital Market Ratios 57
Equity Ratios 58
Profitability Ratios 58
Cost Ratios 59
Liquidity Ratios 59
Leverage Ratios 60
Efficiency Ratios 60

List of Figures
Ferrovial, S.A., Performance Chart (2013 - 2017) 40
Ferrovial, S.A., Ratio Charts 42

★海外企業調査レポート[Ferrovial, S.A. (FER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amgen, Inc.:企業の戦略・SWOT・財務情報
    Amgen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amgen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Athabasca Oil Corp (ATH):石油・ガス:M&Aディール及び事業提携情報
    Summary Athabasca Oil Corp (Athabasca) is an upstream energy company which focuses on exploration, development and production of bitumen, light oil and liquids-rich natural gas from oil sands and related assets. The company employs multi-stage fracturing and horizontal drilling technology from uncon …
  • Ardena Holding NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Ardena Holding NV (Ardena) is a contract development and manufacturing organization. The company offers solid-state chemistry services including polymorph, salt, and co-crystal screening; bio-analytical and formulation development; early-phase clinical supply manufacturing; clinical logistic …
  • Kuzbasskaya Toplivnaya Company:企業の戦略・SWOT・財務分析
    Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report Summary Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • AngioChem Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AngioChem Inc (AngioChem) is a clinical-stage biotechnology company that discovers and develops new drugs to treat brain related disorders. The company’s products comprise oncology products, peptide antibody conjugates, antibody-drug conjugates, pain products and lysosomal storage diseases p …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Ultragenyx Pharmaceutical Inc (RARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Takeda Pharmaceuticals USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • Special Metals Corp:企業の戦略・SWOT・財務分析
    Special Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Special Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PIK-Group:企業のM&A・事業提携・投資動向
    PIK-Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PIK-Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Acceleron Pharma Inc (XLRN)-製薬・医療分野:企業M&A・提携分析
    Summary Acceleron Pharma Inc (AcceleronPharma) is a clinical stage biopharmaceutical company that discovers, developsand commercializes therapeuticsto treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodyspla …
  • Hydro-Quebec-エネルギー分野:企業M&A・提携分析
    Summary Hydro-Quebec is a government-owned energy utility that generates, transmits and distributes electricity. The company specializes in renewable energy generation, using hydro sources and supports the development of electricity using other technologies such as wind energy and biomass. It genera …
  • Alfa Laval AB (ALFA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa Laval AB (Alfa Laval) is a provider of specialized products and solutions for heat transfer, separation and fluid handling. Its product portfolio includes centrifuges, pumps and valves, heat exchangers, thermal fluid systems, boilers, decanters, burners, evaporation systems, high speed …
  • TTK Prestige Limited:企業の戦略・SWOT・財務分析
    TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report Summary TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Organogenesis Inc-医療機器分野:企業M&A・提携分析
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Isovolta AG:企業の戦略的SWOT分析
    Isovolta AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Reichhold LLC 2:企業の戦略的SWOT分析
    Reichhold LLC 2 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆